WIIK PHARMA ApS: Financial statements 2016
CVR: 36481315
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
WIIK PHARMA ApS (CVR 36481315) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,428,031 and a net result of DKK 432,489 compared with DKK -406,100 the year before. That is an increase of 374.7% compared with the year before. Equity in the 2016 report amounted to DKK 76,389. The solvency ratio was 3.7%.
- Gross Profit
- DKK 1,428,031
- Profit/Loss
- DKK 432,489
- Equity
- DKK 76,389
- Total Assets
- DKK 2,067,031
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 1.4 mio. | 432 t. | 76 t. | - |
| 2015 | - | 301 t. | -406 t. | -356 t. | - |
Official annual report
Find more companies like WIIK PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of December 1, 2016, Yacoub Amin Invest ApS is registered as an owner of WIIK PHARMA ApS with an ownership share of 15%.
WIIK PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 300,829, and the net result was DKK -406,100.
About WIIK PHARMA ApS
WIIK PHARMA ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Rune Wiik Kristensen. The board consists of Bernt Skov Jensen (chair), Rune Wiik Kristensen and Yacoub Youssef Ibrahim Amin. The company is owned by Yacoub Amin Invest ApS and Wiik LLC. The company has 4 employees (2018). In 2025, the company reported a gross profit of DKK 7,105,582 and a net result of DKK 2,024,721 compared with DKK 4,385,191 the year before. Equity in the 2025 report amounted to DKK 6,710,672.